INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.410
-0.010 (-0.70%)
At close: May 29, 2026, 4:00 PM EDT
1.409
-0.001 (-0.11%)
After-hours: May 29, 2026, 7:31 PM EDT

INmune Bio Revenue

In the year 2025, INmune Bio had annual revenue of $50.00K with 257.14% growth.

Revenue (ttm)
$50.00K
Revenue Growth
+257.14%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
37.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202550.00K36.00K257.14%
Dec 31, 202414.00K-141.00K-90.97%
Dec 31, 2023155.00K-219.00K-58.56%
Dec 31, 2022374.00K193.00K106.63%
Dec 31, 2021181.00K170.00K1,545.45%
Dec 31, 202011.00K--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition